Skip to search formSkip to main contentSkip to account menu

budralazine

Known as: 1(2H)-Phthalazinone, (1,3-dimethyl-2-butenylidene)hydrazone, 1-(2-(1,3-dimethyl-2-butenylidene)hydrazino)phthalazine, 4-Methyl-3-penten-2-one (1-phthalazinyl)hydrazone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
We studied the effect of chronic antihypertensive treatment with budralazine on the lower blood pressure limit of cerebral blood… 
1986
1986
Budralazine was evaluated for its effect on the cerebral blood flow (CBF) in comparison with some antihypertensive drugs in… 
1985
1985
1983
1983
Intravenous injection of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) to anesthetized dogs resulted in… 
1981
1981
Cardiac presynaptic and vascular postsynaptic alpha-adrenergic effects of 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine… 
1981
1981
In renal hypertensive dogs, 1-[2-(1,3-dimethyl-2-butenylidene)hydrazino]phthalazine (budralazine) at doses of 1 and 2.5 mg/kg p.o… 
1979
1979
1. [14C]Budralazine (I) administered orally to normotensive and spontaneously hypertensive rats showed no significant difference… 
1978
1978
Antihypertensive and pharmacological properties of budralazine were examined in comparison with other antihypertensive drugs… 
1977
1977
The metabolic pathways of budralazine were studied in vivo and in vitro experiments and characterized as follows ; 1) 3-methyl-s…